OOIR: Observatory of International Research

Papers

(The H4-Index of Rheumatology is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Granulomatosis with polyangiitis presenting as obstructive uropathy and vasculitic myopathy	152
Validation of a questionnaire for central nervous system aspects of joint pain: the CAP questionnaire	110
Comment on: Muscle involvement in systemic lupus erythematosus: multimodal ultrasound assessment and relationship with physical performance	96
COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study	78
Comment on: Switching from prednisolone to dexamethasone in difficult-to-treat rheumatoid arthritis	65
Comment on: AI am a rheumatologist: a practical primer to large language models for rheumatologists: reply	64
Comment on: Increased risk of osteoporosis and femoral neck fractures in patients with familial Mediterranean fever—a large retrospective cohort study	64
Boxer’s shape, an unusual finding in nailfold capillaroscopy	63
Correction to: Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis	58
Editor’s Acknowledgement	58
Clinico–pathological phenotypes of systemic sclerosis–associated myopathy: analysis of a large multicentre cohort	56
A case of carpal tunnel syndrome caused by gouty tophi confirmed by dual-source CT	55
Comment on: The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis: reply	52
Prosthetic infections following tocilizumab treatment in patients with rheumatoid arthritis	52
Soluble BDCA-2 as a potential biomarker for rheumatoid arthritis and its role in enhancing IFN-α production through nucleic acid binding	50
Combined radiographic and US evaluations to decipher joint involvement in the hands of patients with SSc	50
Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: multicenter retrospective study	49
OA22 Methotrexate drug monitoring and referral patterns to Hepatology - can we improve detection and monitoring of hepatoxicity with methotrexate use?	49
Giant cell arteritis of the prostate	48
Comment on: Predictors of lack of response to methotrexate in juvenile idiopathic arthritis–associated uveitis	48
E44 Differences of hematological abnormalities between COVID-19 infection and multisystemic inflammatory syndrome (MIS-C)	47
P011 Rituximab and COVID-19 vaccines; are they fit for purpose?	45
29 Juvenile idiopathic arthritis and osteogenesis imperfecta: an exceptional association	44
The state of data sharing in rheumatology: a systematic review of top journal practices	44
P042 Using a Genetic PROBability tool (G-PROB) to aid diagnosis of patients with inflammatory arthritis: results from the Norfolk Arthritis Register	44

P114 Medication adherence to b/tsDMARDS remains sub-optimal in refractory rheumatoid arthritis	43
67 Double impact: hypophosphatemic rickets and vitamin D intoxication	43
P131 Adult coeliac disease and bone mineral density at the femoral neck, total hip and lumbar spine: an age- and sex-matched case-control study	42
P173 The positive utility of PSAID-12 score in remote monitoring and the impact of gender and treatment on patient reported outcomes in psoriatic arthritis	42
E046 Lytic lesions; metastatic disease or gout?	42
OA44 Increasing access to rehabilitation for knee and hip osteoarthritis - ESCAPE-pain in leisure/community centres	41
P143 Frailty is associated with inflammation, impaired glucose metabolism and reduced bone mineral density after adjustment for fat mass index: a UK biobank study	41
P083 Undergraduate rheumatology teaching in the UK: a survey of teachers	41
P073 Functional investigation of Osteoarthritis-associated non-coding variants using CRISPR/Cas9-mediated perturbation of active enhancer regions	41
P107 Long-term efficacy of baricitinib in patients with rheumatoid arthritis with inadequate response to bDMARDs: results from RA-BEYOND up to 6.9-years of treatment	40
P058 Pneumocystis Jirovecii Infection in autoimmune inflammatory rheumatic diseases in Oxford	40
P033 The intriguing association between fibromyalgia, hypermobility and neurodivergence: a pilot study	39
E051 Audit of the management of patients over 75 with osteoporotic fragility fractures in primary care	39
P041 Successful reversal of microvascular damage with standard therapy in a case of dermatomyositis overlap syndrome	39